© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 21, 1753-1763,
November 1, 2000
© 2000 Oxford University Press
Prospective Study of Serum Selenium Levels and Incident Esophageal and Gastric Cancers
Affiliations of authors: S. D. Mark, H. Katki, J. F. Fraumeni, Jr. (Division of Cancer Epidemiology and Genetics), S. M. Dawsey, P. R. Taylor (Division of Clinical Science), National Cancer Institute, Bethesda, MD; Y.-L. Qiao, Y.-P. Wu, Z.-W. Dong, Department of Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China; E. W. Gunter, National Health and Nutrition Examination Survey Laboratory, Centers for Disease Control and Prevention, Atlanta, GA; W. J. Blot, International Epidemiology Institute, Rockville, MD.
Correspondence to: Steven D. Mark, M.D., Sc.D., National Institutes of Health, 6120 Executive Blvd., Rm. 8036 MSC 7244, Rockville, MD 20852-4910 (e-mail: sm7v{at}.nih.gov).
Background: From March 1986 through May 1991, we conducted a randomized nutritional intervention trial, the General Population Trial, in Linxian, China, a region with epidemic rates of squamous esophageal and adenomatous gastric cardia cancers. We found that participants who received selenium, ß-carotene, and vitamin E had significantly lower cancer mortality rates than those who did not. In the current study, we examined the relationship between selenium levels measured in pretrial (1985) sera from participants and the subsequent risk of developing squamous esophageal, gastric cardia, and gastric non-cardia cancers during the trial. Methods: This study was designed and analyzed in accord with a stratified case–cohort sampling scheme, with the six strata defined by sex and three age categories. We measured serum selenium levels in 590 case subjects with esophageal cancer, 402 with gastric cardia cancers, and 87 with gastric non-cardia cancers as well as in 1062 control subjects. Relative risks (RRs), absolute risks, and population attributable risk for cancers were estimated on the basis of the Cox proportional hazards models. All statistical tests are two-sided. Results: We found highly significant inverse associations of serum selenium levels with the incidence of esophageal (P for trend <10-4) and gastric cardia (P for trend <10-6) cancers. The RR and 95% confidence interval (CI) for comparison of highest to lowest quartile of serum selenium was 0.56 (95% CI = 0.44–0.71) for esophageal cancer and 0.47 (95% CI = 0.33–0.65) for gastric cardia cancer. The population proportion of these cancers that is attributable to low selenium levels was 26.4% (95% CI = 14.45–38.36). We found no evidence for a gradient of serum selenium associated with incidence of gastric non-cardia cancer (P for trend = .96), with an RR of 1.07 (95% CI = 0.55–2.08) for the highest to lowest quartile of serum selenium. Conclusions: Our study supports findings from previous prospective studies and randomized trials that variations in selenium levels affect the incidence of certain cancers. In the United States, where intervention trials of selenium are in the planning stages, consideration should be given to including populations at high risk for squamous esophageal and gastric cardia cancers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. J. Adams A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium Bioscience Horizons, March 1, 2008; 1(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Abnet, W. Chen, S. M. Dawsey, W.-Q. Wei, M. J. Roth, B. Liu, N. Lu, P. R. Taylor, and Y.-L. Qiao Serum 25(OH)-Vitamin D Concentration and Risk of Esophageal Squamous Dysplasia Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1889 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Taylor Prevention of Gastric Cancer: A Miss J Natl Cancer Inst, January 17, 2007; 99(2): 101 - 103. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al. Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. McGlynn, C. C. Abnet, M. Zhang, X.-D. Sun, J.-H. Fan, T. R. O'Brien, W.-Q. Wei, B. A. Ortiz-Conde, S. M. Dawsey, J.-P. Weber, et al. Serum concentrations of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and risk of primary liver cancer. J Natl Cancer Inst, July 19, 2006; 98(14): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Joshi, L. L. Johnson, W.-Q. Wei, C. C. Abnet, Z.-W. Dong, P. R. Taylor, P. J. Limburg, S. M. Dawsey, E. T. Hawk, Y.-L. Qiao, et al. Gene Expression Differences in Normal Esophageal Mucosa Associated with Regression and Progression of Mild and Moderate Squamous Dysplasia in a High-Risk Chinese Population. Cancer Res., July 1, 2006; 66(13): 6851 - 6860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kamangar, G. M. Dores, and W. F. Anderson Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World J. Clin. Oncol., May 10, 2006; 24(14): 2137 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Joshi, L. L. Johnson, W.-Q. Wei, C. C. Abnet, Z.-W. Dong, P. R. Taylor, P. J. Limburg, S. M. Dawsey, E. T. Hawk, Y.-L. Qiao, et al. Selenomethionine treatment does not alter gene expression in normal squamous esophageal mucosa in a high-risk chinese population. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1046 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cai, L.-N. Mu, H. Lu, Q.-Y. Lu, N.-C. Y. You, S.-Z. Yu, A. D. Le, J. Zhao, X.-F. Zhou, J. Marshall, et al. Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 294 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Souza and S. J. Spechler Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach CA Cancer J Clin, November 1, 2005; 55(6): 334 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. T. Akbaraly, J. Arnaud, I. Hininger-Favier, V. Gourlet, A.-M. Roussel, and C. Berr Selenium and Mortality in the Elderly: Results from the EVA Study Clin. Chem., November 1, 2005; 51(11): 2117 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-Q Wei, C C Abnet, N Lu, M J Roth, G-Q Wang, B A Dye, Z-W Dong, P R Taylor, P Albert, Y-L Qiao, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China Gut, June 1, 2005; 54(6): 759 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Abnet, B. Lai, Y.-L. Qiao, S. Vogt, X.-M. Luo, P. R. Taylor, Z.-W. Dong, S. D. Mark, and S. M. Dawsey Zinc Concentration in Esophageal Biopsy Specimens Measured by X-Ray Fluorescence and Esophageal Cancer Risk J Natl Cancer Inst, February 16, 2005; 97(4): 301 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Taylor and P. Greenwald Nutritional Interventions in Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Variants of the IL8 and IL8RB Genes and Risk for Gastric Cardia Adenocarcinoma and Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, K. Haque, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Polymorphisms in Interleukin -2, -6, and -10 Are Not Associated with Gastric Cardia or Esophageal Cancer in a High-Risk Chinese Population Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1547 - 1549. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Wei, C. C Abnet, Y.-L. Qiao, S. M Dawsey, Z.-W. Dong, X.-D. Sun, J.-H. Fan, E. W Gunter, P. R Taylor, and S. D Mark Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death Am. J. Clinical Nutrition, January 1, 2004; 79(1): 80 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Irmak, G. Ince, M. Ozturk, and R. Cetin-Atalay Acquired Tolerance of Hepatocellular Carcinoma Cells to Selenium Deficiency: A Selective Survival Mechanism? Cancer Res., October 15, 2003; 63(20): 6707 - 6715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Taylor, Y.-L. Qiao, C. C. Abnet, S. M. Dawsey, C. S. Yang, E. W. Gunter, W. Wang, W. J. Blot, Z.-W. Dong, and S. D. Mark Prospective Study of Serum Vitamin E Levels and Esophageal and Gastric Cancers J Natl Cancer Inst, September 17, 2003; 95(18): 1414 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Rudolph, T. L. Vaughan, A. R. Kristal, P. L. Blount, D. S. Levine, P. C. Galipeau, L. J. Prevo, C. A. Sanchez, P. S. Rabinovitch, and B. J. Reid Serum Selenium Levels in Relation to Markers of Neoplastic Progression Among Persons With Barrett's Esophagus J Natl Cancer Inst, May 21, 2003; 95(10): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, Y. Jiang, X. Ma, K. Yang, L. Egevad, and P. Lindblad Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors Carcinogenesis, May 1, 2002; 23(5): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Dong, P. Tang, L. Li, and G. Wang The Strategy for Esophageal Cancer Control in High-risk Areas of China Jpn. J. Clin. Oncol., February 1, 2002; 32(90001): S10 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ghose, J. Fleming, K. El-Bayoumy, and P. R. Harrison Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-activated Protein Kinase and Fas Pathways Cancer Res., October 1, 2001; 61(20): 7479 - 7487. [Abstract] [Full Text] [PDF]
|
|